Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol plus enoximone versus esmolol alone for perioperative hemodynamic optimization in coronary artery disease
2005-004617-15Phase 3Active
- Sponsor
- Klinikum Ludwigshafen
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in coronary arteriosclerosis comparing Esmolol + enoximone with Esmolol alone (2 arms). Started Aug 2006; status: active.
02
Drugs
esmololenoximone
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2005-004617-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004617-15.